合計 50 件の最近のインサイダー取引記録が記録されています Tempest Therapeutics, Inc. (TPST), 内訳は 46 件の買い および 3 件の売り. インサイダー買い総額は $16.6M インサイダー売り総額は $989.93K.
最近活動のある主要インサイダーには Maestas Nicholas, Trojanowski Justin, Angel Matthew. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — TPST
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-31 |
Maestas Nicholas |
Chief Financial Officer |
RSU 付与（制限付株式） |
140,000 |
$1.64 |
$229.6K |
140,000 |
| 2026-03-31 |
Trojanowski Justin |
Corporate Controller |
RSU 付与（制限付株式） |
22,000 |
$1.64 |
$36.08K |
22,000 |
| 2026-03-24 |
Angel Matthew |
10 Percent Owner, Officer: CEO and President |
情報に基づく買い |
231,482 |
$2.16 |
$500K |
231,482 |
| 2026-02-04 |
Angel Matthew |
10 Percent Owner, Officer: CEO and President |
RSU 付与（制限付株式） |
269,621 |
$2.38 |
$641.7K |
269,621 |
| 2026-02-03 |
Angel Matthew |
10 Percent Owner, Officer: CEO and President |
不明 |
- |
- |
- |
8,268,495 |
| 2026-01-27 |
Pellizzari Christine A |
Director |
RSU 付与（制限付株式） |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2026-01-27 |
Nichol Geoffrey |
Director |
RSU 付与（制限付株式） |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2026-01-27 |
Raab Michael |
Director |
RSU 付与（制限付株式） |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2026-01-27 |
Simantov Ronit |
Director |
RSU 付与（制限付株式） |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2025-01-02 |
Brady Stephen R |
President and CEO |
RSU 付与（制限付株式） |
550,000 |
$0.86 |
$473K |
550,000 |
| 2025-01-02 |
Whiting Samuel |
Chief Medical Officer |
RSU 付与（制限付株式） |
270,000 |
$0.86 |
$232.2K |
270,000 |
| 2025-01-02 |
Maestas Nicholas |
Chief Financial Officer |
RSU 付与（制限付株式） |
200,000 |
$0.86 |
$172K |
200,000 |
| 2025-01-02 |
Trojanowski Justin |
Corporate Controller |
RSU 付与（制限付株式） |
30,000 |
$0.86 |
$25.8K |
30,000 |
| 2024-08-12 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
情報に基づく売り |
387,999 |
$1.10 |
$426.99K |
209,941 |
| 2024-08-08 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
情報に基づく売り |
400,000 |
$1.35 |
$540.04K |
597,940 |
| 2024-07-03 |
Brady Stephen R |
President and CEO |
情報に基づく買い |
35,000 |
$2.11 |
$73.85K |
46,376 |
| 2024-07-02 |
Whiting Samuel |
Chief Medical Officer |
情報に基づく買い |
4,672 |
$2.13 |
$9.95K |
9,573 |
| 2024-06-28 |
Trojanowski Justin |
Corporate Controller |
情報に基づく買い |
7,500 |
$2.16 |
$16.2K |
22,168 |
| 2024-06-13 |
Pellizzari Christine A |
Director |
RSU 付与（制限付株式） |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-06-13 |
Nichol Geoffrey |
Director |
RSU 付与（制限付株式） |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-06-13 |
Raab Michael |
Director |
RSU 付与（制限付株式） |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-06-13 |
Simantov Ronit |
Director |
RSU 付与（制限付株式） |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-01-03 |
Brady Stephen R |
President and CEO |
RSU 付与（制限付株式） |
250,000 |
$4.66 |
$1.17M |
250,000 |
| 2024-01-03 |
Whiting Samuel |
Chief Medical Officer |
RSU 付与（制限付株式） |
100,000 |
$4.66 |
$466K |
100,000 |
| 2024-01-03 |
Maestas Nicholas |
VP of Strategy and Finance |
RSU 付与（制限付株式） |
40,000 |
$4.66 |
$186.4K |
40,000 |
| 2024-01-03 |
Trojanowski Justin |
Principal Accounting Officer |
RSU 付与（制限付株式） |
26,500 |
$4.66 |
$123.49K |
26,500 |
| 2023-10-11 |
Brady Stephen R |
President and CEO |
RSU 付与（制限付株式） |
725,000 |
$9.77 |
$7.08M |
725,000 |
| 2023-10-11 |
Whiting Samuel |
Chief Medical Officer |
RSU 付与（制限付株式） |
325,000 |
$9.77 |
$3.18M |
325,000 |
| 2023-10-11 |
Maestas Nicholas |
VP of Strategy and Finance |
RSU 付与（制限付株式） |
100,000 |
$9.77 |
$977K |
100,000 |
| 2023-10-11 |
Trojanowski Justin |
Corporate Controller |
RSU 付与（制限付株式） |
55,000 |
$9.77 |
$537.35K |
55,000 |
| 2023-06-15 |
Pellizzari Christine A |
Director |
RSU 付与（制限付株式） |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-06-15 |
Nichol Geoffrey |
Director |
RSU 付与（制限付株式） |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-06-15 |
Raab Michael |
Director |
RSU 付与（制限付株式） |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-06-15 |
Simantov Ronit |
Director |
RSU 付与（制限付株式） |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-01-03 |
Brady Stephen R |
Chief Executive Officer |
RSU 付与（制限付株式） |
177,300 |
- |
- |
177,300 |
| 2023-01-03 |
Dubensky Thomas W. |
President |
RSU 付与（制限付株式） |
102,700 |
- |
- |
102,700 |
| 2023-01-03 |
Whiting Samuel |
Chief Medical Officer |
RSU 付与（制限付株式） |
69,700 |
- |
- |
69,700 |
| 2023-01-03 |
Maestas Nicholas |
VP of Strategy and Finance |
RSU 付与（制限付株式） |
38,425 |
- |
- |
38,425 |
| 2023-01-03 |
Trojanowski Justin |
Corporate Controller |
RSU 付与（制限付株式） |
20,300 |
- |
- |
20,300 |
| 2022-10-03 |
Trojanowski Justin |
Corporate Controller |
RSU 付与（制限付株式） |
2,500 |
- |
- |
2,500 |
| 2022-09-30 |
Trojanowski Justin |
Corporate Controller |
処分 |
10,000 |
$2.29 |
$22.9K |
- |
| 2022-06-22 |
Whiting Samuel |
Chief Medical Officer |
RSU 付与（制限付株式） |
55,680 |
- |
- |
55,680 |
| 2022-06-21 |
Brady Stephen R |
Chief Executive Officer |
RSU 付与（制限付株式） |
173,533 |
- |
- |
173,533 |
| 2022-06-21 |
Dubensky Thomas W. |
President |
RSU 付与（制限付株式） |
87,801 |
$2.35 |
$206.33K |
87,801 |
| 2022-06-21 |
Lorenzo Pierre |
Corporate Controller |
RSU 付与（制限付株式） |
8,477 |
- |
- |
8,477 |
| 2022-06-21 |
Maestas Nicholas |
VP of Strategy and Finance |
RSU 付与（制限付株式） |
51,270 |
- |
- |
51,270 |
| 2022-06-17 |
Pellizzari Christine A |
Director |
RSU 付与（制限付株式） |
3,500 |
- |
- |
3,500 |
| 2022-06-17 |
Nichol Geoffrey |
Director |
RSU 付与（制限付株式） |
3,500 |
$2.08 |
$7.28K |
3,500 |
| 2022-06-17 |
Raab Michael |
Director |
RSU 付与（制限付株式） |
3,500 |
- |
- |
3,500 |
| 2022-06-17 |
Woiwode Thomas |
Director |
RSU 付与（制限付株式） |
3,500 |
$2.08 |
$7.28K |
3,500 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
